Evidence map›Paper›PMID 27511018›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.

Gunjan D Manocha, Angela M Floden, Keiko Rausch, Joshua A Kulas, Brett A McGregor, Lalida Rojanathammanee, Kelley R Puig, Kendra L Puig, Sanjib Karki, Michael R Nichols and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  13. Review
  14. Review
  15. The clock modulator Nobiletin mitigates astrogliosis-associated neuroinflammation and disease hallmarks in an Alzheimer's disease model.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Gunjan D ManochaDepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203.ORCID 0000-0003-4488-6627
Angela M FlodenDepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203.
Keiko RauschDepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203.ORCID 0000-0001-7146-9787
Joshua A KulasDepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203.ORCID 0000-0002-8055-1894
Brett A McGregorDepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203.ORCID 0000-0003-3146-9699
Lalida RojanathammaneeInstitute of Science, Suranaree University of Technology, Nakhon Ratchasima, 30000 Thailand.
Kelley R PuigDepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203.ORCID 0000-0002-2155-8877
Kendra L PuigDepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203.
Sanjib KarkiDepartment of Chemistry and Biochemistry, University of Missouri-St. Louis, St. Louis, Missouri 63121-4400, and.ORCID 0000-0003-2189-9329
Michael R NicholsDepartment of Chemistry and Biochemistry, University of Missouri-St. Louis, St. Louis, Missouri 63121-4400, and.
Diane C DarlandDepartment of Biology, University of North Dakota, Grand Forks, North Dakota 58202.ORCID 0000-0001-5567-1889
James E PorterDepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203.
Colin K CombsDepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203, colin.combs@med.und.edu.
University of North Dakota · USUniversity of Missouri–St. Louis · USSuranaree University of Technology · TH

Funding

APP Regulates Brain and Adipose Changes in ObesityR01AG042819 · NIA · UNIVERSITY OF NORTH DAKOTA · PI COMBS, COLIN K, GOLOVKO, MIKHAIL Y · 2012 to 2016
$1.4M
Abeta is a Proinflammatory Ligand for Microglial APPR01AG026330 · NIA · UNIVERSITY OF NORTH DAKOTA · PI COMBS, COLIN K · 2007 to 2010
$676k
NIA NIH HHS R01 AG026330NIA NIH HHS R01 AG042819
6 · The paper itself

Abstract

unlabelledPrior work suggests that amyloid precursor protein (APP) can function as a proinflammatory receptor on immune cells, such as monocytes and microglia. Therefore, we hypothesized that APP serves this function in microglia during Alzheimer's disease. Although fibrillar amyloid β (Aβ)-stimulated cytokine secretion from both wild-type and APP knock-out (mAPP(-/-)) microglial cultures, oligomeric Aβ was unable to stimulate increased secretion from mAPP(-/-) cells. This was consistent with an ability of oligomeric Aβ to bind APP. Similarly, intracerebroventricular infusions of oligomeric Aβ produced less microgliosis in mAPP(-/-) mice compared with wild-type mice. The mAPP(-/-) mice crossed to an APP/PS1 transgenic mouse line demonstrated reduced microgliosis and cytokine levels and improved memory compared with wild-type mice despite robust fibrillar Aβ plaque deposition. These data define a novel function for microglial APP in regulating their ability to acquire a proinflammatory phenotype during disease. SIGNIFICANCE STATEMENT: A hallmark of Alzheimer's disease (AD) brains is the accumulation of amyloid β (Aβ) peptide within plaques robustly invested with reactive microglia. This supports the notion that Aβ stimulation of microglial activation is one source of brain inflammatory changes during disease. Aβ is a cleavage product of the ubiquitously expressed amyloid precursor protein (APP) and is able to self-associate into a wide variety of differently sized and structurally distinct multimers. In this study, we demonstrate both in vitro and in vivo that nonfibrillar, oligomeric forms of Aβ are able to interact with the parent APP protein to stimulate microglial activation. This provides a mechanism by which metabolism of APP results in possible autocrine or paracrine Aβ production to drive the microgliosis associated with AD brains.

Indexed as

Adaptation, OcularAlzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsAstrocytesCell ProliferationCells, CulturedCytokinesDisease Models, AnimalExploratory BehaviorHumansMiceMice, Inbred C57BLMice, TransgenicMicrogliaAmyloid beta-PeptidesAmyloid beta-Protein PrecursorCytokinesMorpholinosPresenilin-1PSEN1 protein, humanAlzheimer's diseaseamyloid precursor proteinamyloid β oligomersmicroglianeuroinflammation

Identifiers

PMID27511018
PMCPMC4978805
OpenAlexW2487210382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.